These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 405166)

  • 21. Concomitant immunization by the fully antigenic counterparts prevents modulated tumor cells from escaping cellular immune elimination.
    De Boer RJ; Michelson S; Hogeweg P
    J Immunol; 1986 Jun; 136(11):4319-27. PubMed ID: 2939142
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The immunobiological properties of trimezon and levamisole on models of humoral and cell-mediated immunogenesis].
    Liubin GS; Kuz'mitskiĭ BB
    Eksp Klin Farmakol; 1997; 60(1):50-2. PubMed ID: 9162286
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Leukocyte-dependent antibody in sheep immunized with murine mastocytoma cells.
    Grant CK; Adams E; Miller HR
    Eur J Immunol; 1975 May; 5(5):324-30. PubMed ID: 824135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition by selected anticancer agents of the development of primary cell-mediated immunity against allogeneic tumor cells in culture.
    Orsini F; Eppolito C; Ehrke MJ; Mihich E
    Cancer Treat Rep; 1980; 64(2-3):211-8. PubMed ID: 6967756
    [No Abstract]   [Full Text] [Related]  

  • 25. Antibody-dependent human lymphocytotoxicity: a micro assay system.
    Zeijlemaker WP; Roos MT; Schellekens PT; Eijsvoogel VP
    Eur J Immunol; 1975 Aug; 5(8):579-84. PubMed ID: 824141
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of levamisole on cell-mediated immunity and suppressor cell function.
    Sampson D; Lui A
    Cancer Res; 1976 Mar; 36(3):952-5. PubMed ID: 1253182
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Allograft immunity in the mouse. 1. Quantitation and specificity of cytotoxic effector cells after in vitro sensitization.
    MacDonald HR; Phillips RA; Miller RG
    J Immunol; 1973 Aug; 111(2):565-74. PubMed ID: 4123983
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of age on cell-mediated immunity in long-lived mice.
    Goodman SA; Makinodan T
    Clin Exp Immunol; 1975 Mar; 19(3):533-42. PubMed ID: 812622
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A hypothesis. The mechanism of action of levamisole: immune restoration through enhanced cell maturation.
    Amery WK
    J Reticuloendothel Soc; 1978 Aug; 24(2):187-93. PubMed ID: 309007
    [No Abstract]   [Full Text] [Related]  

  • 30. Selective activation of T lymphocytes. Its possible application in the immunomanipulation of tumours.
    Miller JF
    Biomedicine; 1973 Mar; 18(2):81-5. PubMed ID: 4199988
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparative study of in vitro and in vivo drug effects on cell-mediated cytotoxicity.
    Borel JF
    Immunology; 1976 Oct; 31(4):631-41. PubMed ID: 824198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Levamisole synergizes experimental F4ac+ Escherichia coli oral vaccine in stimulating ileal Peyer's patch T cells in weaned pigs.
    Bozić F; Lacković G; Kovsca-Janjatović A; Smolec O; Valpotić I
    J Vet Pharmacol Ther; 2006 Jun; 29(3):199-204. PubMed ID: 16669864
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potentiation of T-cell mediated immunity by levamisole.
    Renoux G; Renoux M; Teller MN; McMahon S; Guillaumin JM
    Clin Exp Immunol; 1976 Aug; 25(2):288-96. PubMed ID: 782749
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors affecting suppressor cell activity in tumor-allosensitized mice.
    Argyris BF
    J Natl Cancer Inst; 1980 Apr; 64(4):959-66. PubMed ID: 6445017
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitation of the cell-mediated immune response. I. The number of cytolytically active mouse lymphoid cells induced by immunization with allogeneic mastocytoma cells.
    Henney CS
    J Immunol; 1971 Dec; 107(6):1558-66. PubMed ID: 5000987
    [No Abstract]   [Full Text] [Related]  

  • 36. Increase in histamine receptors on thymus-derived effector lymphocytes during the primary immune response to alloantigens.
    Plaut M; Lichtenstein LM; Henney CS
    Nature; 1973 Aug; 244(5414):284-7. PubMed ID: 4147637
    [No Abstract]   [Full Text] [Related]  

  • 37. Cytotoxic lymphocytes from normal donors. A functional marker of human non-T lymphocytes.
    Pross HF; Jondal M
    Clin Exp Immunol; 1975 Aug; 21(2):226-35. PubMed ID: 810282
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sensitivity of cytotoxic T cells to T-cell mediated cytotoxicity.
    Golstein P
    Nature; 1974 Nov; 252(5478):81-3. PubMed ID: 4215028
    [No Abstract]   [Full Text] [Related]  

  • 39. Characterization of the immunostimulatory activity of levamisole.
    Mantovani A; Spreafico F
    Boll Ist Sieroter Milan; 1974; 53(1):suppl:302. PubMed ID: 4859247
    [No Abstract]   [Full Text] [Related]  

  • 40. Augmenting major histocompatibility complex class I expression by murine tumors in vivo enhances antitumor immunity induced by an active immunotherapy strategy.
    Merritt RE; Yamada RE; Crystal RG; Korst RJ
    J Thorac Cardiovasc Surg; 2004 Feb; 127(2):355-64. PubMed ID: 14762342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.